CHANGE IN RATINGS
upgraded at Goldman Sachs to Buy from Neutral, based on market share gains, international expansion, and opportunity in skincare. See upside to 2007 estimates if management accelerated timing of rollouts. Price target raised to $44 from $33.
upgraded at Bear Stearns to Peer Perform. Company is exploring strategic alternatives, but may only sell a piece of its business. Stock could ultimately be taken out in the mid-$50's.
upgraded at JP Morgan from Neutral to Overweight. Business fundamentals are improving, which could produce potential earnings upside. Company is also gaining market share in analog.
upgraded at UBS to Buy rating from Neutral. Price target lifts to $37 from $34 and 2008 EPS estimates hold at $2.00.
downgraded to Reduce at Suntrust Robinson Humphrey. License growth has not re-accelerated in the first half of 2007, as expected.
upgraded from Market Perform to Outperform at Bernstein. $77 price target, as the stock should outperform KO by at least 10% over the next year.
downgraded from Outperform to Sector Perform at CIBC. Company lacks near-term catalysts to drive the stock even higher. Macro environment remains murky, though estimates still raised through 2008.
STOCK COMMENTS / EPS CHANGES
numbers raised at Jefferies. Price target jumps to $99 from $82 and 2008 EPS estimates rise to loss of ($0.66) from ($1.67). Reiterates Buy rating.
Research in Motion
target price raised at Credit Suisse to $100 from $75 but maintained Underperform rating based on margin pressure following inline 4Q results. Believes risk/reward is unfavorable.
numbers now seen reaching $35 at Bear Stearns. Estimates also raised, to reflect a robust launch of Panama. Branded growth is also tracking well. Outperform rating.